FIELD: medicine, pharmacy. SUBSTANCE: invention relates to pharmaceutical composition comprising water-insoluble active compound 17-allyl-1,14-dihydroxy-12-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylvinyl] -23,25- dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo-[22.3.1. 04,9]-octacos-18-ene-2,3,10,16- tetraone, surface-active substance and solid carrier that promotes to enhancement of solubility and improvement of absorption of this composition in oral route of administration. EFFECT: improved properties of composition. 7 cl, 1 tbl, 1 dwg, 5 ex
Title | Year | Author | Number |
---|---|---|---|
IMMUNOSUPPRESSIVE COMPOSITION AND A METHOD OF ITS SYNTHESIS | 1991 |
|
RU2084222C1 |
PHARMACEUTICAL COMPOSITION | 1999 |
|
RU2203058C2 |
PHARMACEUTICAL SOLUTION | 1991 |
|
RU2028142C1 |
PHARMACEUTICAL COMPOSITION SHOWING IMMUNOSUPPRESSIVE AND ANTIMICROBIAL ACTIVITIES | 1991 |
|
RU2079304C1 |
SUSTAINED-RELEASE PREPARATIONS | 1999 |
|
RU2214244C2 |
AMIDES OF ACIDS, METHOD FOR THEIR PREPARING AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2000 |
|
RU2208608C2 |
INHIBITOR OF INTIMA HYPERTROPHY, USE OF HYDROXYINDOLE DERIVATIVE FOR SYNTHESIS OF INHIBITOR OF INTIMA HYPERTROPHY, COMPOSITIONS FOR INHIBITION OF INTIMA HYPERTROPHY, METHOD OF PROPHYLAXIS AND TREATMENT OF INTIMA HYPERTROPHY | 1997 |
|
RU2145852C1 |
PEPTIDE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF INHIBITION OF TACHYKININ EFFECT | 1993 |
|
RU2119922C1 |
STABILIZED PHARMACEUTIC COMPOSITION IN ITS LYOPHILIZED FORM | 2000 |
|
RU2251411C2 |
PHARMACEUTICAL COMPOSITION CONTAINING 2,3-DIHYDRO-6-NITROIMIDAZO[2,1-b]OXAZOLE DERIVATIVES | 2006 |
|
RU2413504C2 |
Authors
Dates
2003-01-27—Published
1997-12-05—Filed